Ignite Creation Date:
2025-12-24 @ 2:24 PM
Ignite Modification Date:
2026-04-02 @ 12:21 AM
Study NCT ID:
NCT00611559
Status:
COMPLETED
Last Update Posted:
2018-06-06
First Post:
2008-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02-14
Start Date Type:
None
Primary Completion Date:
2008-06-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-06-25
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-29
First Submit QC Date:
None
Study First Post Date:
2008-02-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2009-06-22
Results First Submit QC Date:
None
Results First Post Date:
2009-08-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-27
Last Update Post Date:
2018-06-06
Last Update Post Date Type:
ACTUAL